Zhang YB - Search Results

1

Specific inhibitor of Notch‑3 enhances the sensitivity of NSCLC cells to gemcitabine.

Hu BD, Guo J, Ye YZ, Du T, Cheng CS, Jiang Q, Liu RN, Zhang YB. Hu BD, et al. Among authors: zhang yb. Oncol Rep. 2018 Jul;40(1):155-164. doi: 10.3892/or.2018.6448. Epub 2018 May 16. Oncol Rep. 2018. PMID: 29781034 Free PMC article.

2

Increased expression of Toll-like receptors 4 and 9 in human lung cancer.

Zhang YB, He FL, Fang M, Hua TF, Hu BD, Zhang ZH, Cao Q, Liu RY. Zhang YB, et al. Among authors: zhang zh. Mol Biol Rep. 2009 Jul;36(6):1475-81. doi: 10.1007/s11033-008-9338-9. Epub 2008 Sep 2. Mol Biol Rep. 2009. PMID: 18763053

3

[Mechanism of regulation of leptin expression in human lung adenocarcinoma cells by hypoxia inducible factor-1alpha: a preliminary study].

Zhang YB, Fang M, He FL, Hua TF, Hu BD, Zhao H, Liu RY. Zhang YB, et al. Zhonghua Yi Xue Za Zhi. 2008 Nov 4;88(40):2848-53. Zhonghua Yi Xue Za Zhi. 2008. PMID: 19080496 Chinese.

4

Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer.

Ye YZ, Zhang ZH, Fan XY, Xu XL, Chen ML, Chang BW, Zhang YB. Ye YZ, et al. Among authors: zhang yb, zhang zh. Med Oncol. 2013;30(2):595. doi: 10.1007/s12032-013-0595-7. Epub 2013 May 7. Med Oncol. 2013. PMID: 23645556

5

Notch signaling molecules as prognostic biomarkers for non-small cell lung cancer.

Jin MM, Ye YZ, Qian ZD, Zhang YB. Jin MM, et al. Among authors: zhang yb. Oncol Lett. 2015 Nov;10(5):3252-3260. doi: 10.3892/ol.2015.3662. Epub 2015 Sep 2. Oncol Lett. 2015. PMID: 26722321 Free PMC article.

6

Synergistic Effect of Notch-3-Specific Inhibition and Paclitaxel in Non-Small Cell Lung Cancer (NSCLC) Cells Via Activation of The Intrinsic Apoptosis Pathway.

He F, Du T, Jiang Q, Zhang Y. He F, et al. Med Sci Monit. 2017 Aug 3;23:3760-3769. doi: 10.12659/msm.902641. Med Sci Monit. 2017. PMID: 28769027 Free PMC article.

7

Effects of reduced platelet count on the prognosis for patients with non-small cell lung cancer treated with EGFR-TKI: a retrospective study.

Xu L, Xu F, Kong H, Zhao M, Ye Y, Zhang Y. Xu L, et al. BMC Cancer. 2020 Nov 26;20(1):1152. doi: 10.1186/s12885-020-07650-2. BMC Cancer. 2020. PMID: 33243184 Free PMC article.

8

The efficacy of Raman spectroscopy in lung cancer diagnosis: the first diagnostic meta-analysis.

Ke ZY, Ning YJ, Jiang ZF, Zhu YY, Guo J, Fan XY, Zhang YB. Ke ZY, et al. Among authors: zhang yb. Lasers Med Sci. 2022 Feb;37(1):425-434. doi: 10.1007/s10103-021-03275-4. Epub 2021 Apr 15. Lasers Med Sci. 2022. PMID: 33856584

9

Excellent response of lung adenocarcinoma harboring a rare SLC8A1 downstream intergenic region ALK fusion to ceritinib treatment: A case report.

Fang L, Ding G, Wang M, Ye Y, Yan X, Ding P, Wang J, Zhang Y. Fang L, et al. Medicine (Baltimore). 2022 Aug 26;101(34):e30255. doi: 10.1097/MD.0000000000030255. Medicine (Baltimore). 2022. PMID: 36042596 Free PMC article.

10

Clinicopathological and molecular characterization of resected lung adenocarcinoma: Correlations with histopathological grading systems in Chinese patients.

Xia W, Zhang S, Ye Y, Xiao H, Zhang Y, Ning G, Zhang Y, Wang W, Fei GH. Xia W, et al. Pathol Res Pract. 2024 Jul;259:155359. doi: 10.1016/j.prp.2024.155359. Epub 2024 May 23. Pathol Res Pract. 2024. PMID: 38810376

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,075 results

Search Page

Filters